Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT

• Status: Terminated
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate whether an alpha-glucosidase inhibitor, a drug for the suppression of postprandial hyperglycemia, could reduce the recurrence of myocardial infarction in patients with impaired glucose tolerance (IGT) and old myocardial infarction.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Cerebral and Cardiovascular Center
• Collaborator: Ministry of Health, Labor and Welfare (Japan)
• Treatments: Glycoside Hydrolase Inhibitors; Voglibose

Criteria

Inclusion Criteria:

1. Impaired glucose tolerance

2. History of myocardial infarction

Exclusion Criteria:

1. Type I diabetes

2. History of coronary artery bypass graft

3. Severe liver and/or kidney dysfunction

4. History of allergic response to drugs

5. Arteriosclerosis obliterans